These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30380596)

  • 1. The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity.
    Poleszczuk J; Enderling H
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations.
    Johnsrud AJ; Jenkins SV; Jamshidi-Parsian A; Quick CM; Galhardo EP; Dings RPM; Vang KB; Narayanasamy G; Makhoul I; Griffin RJ
    Radiat Res; 2020 Dec; 194(6):688-697. PubMed ID: 33348372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
    Ye JC; Formenti SC
    Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
    Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
    J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
    Demaria S; Guha C; Schoenfeld J; Morris Z; Monjazeb A; Sikora A; Crittenden M; Shiao S; Khleif S; Gupta S; Formenti SC; Vikram B; Coleman CN; Ahmed MM
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?
    Marconi R; Strolin S; Bossi G; Strigari L
    PLoS One; 2017; 12(2):e0171559. PubMed ID: 28222111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.
    Vanpouille-Box C; Diamond JM; Pilones KA; Zavadil J; Babb JS; Formenti SC; Barcellos-Hoff MH; Demaria S
    Cancer Res; 2015 Jun; 75(11):2232-42. PubMed ID: 25858148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model.
    Basler L; Kowalczyk A; Heidenreich R; Fotin-Mleczek M; Tsitsekidis S; Zips D; Eckert F; Huber SM
    Cancer Immunol Immunother; 2018 Apr; 67(4):653-662. PubMed ID: 29335856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abscopal effect: Myth or reality?].
    Mirjolet C; Truc G
    Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma.
    Chakwizira A; Ahlstedt J; Nittby Redebrandt H; Ceberg C
    Br J Radiol; 2018 Jul; 91(1087):20170857. PubMed ID: 29688039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation as an immunological adjuvant: current evidence on dose and fractionation.
    Demaria S; Formenti SC
    Front Oncol; 2012; 2():153. PubMed ID: 23112958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude mice.
    Couillard S; Gutman M; Labrie F; Candas B; Labrie C
    Cancer Res; 1999 Oct; 59(19):4857-63. PubMed ID: 10519396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced immune response in novel radiotherapy approaches FLASH and spatially fractionated radiotherapies.
    Bertho A; Iturri L; Prezado Y
    Int Rev Cell Mol Biol; 2023; 376():37-68. PubMed ID: 36997269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awakening the immune system with radiation: Optimal dose and fractionation.
    Gandhi SJ; Minn AJ; Vonderheide RH; Wherry EJ; Hahn SM; Maity A
    Cancer Lett; 2015 Nov; 368(2):185-90. PubMed ID: 25799953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of anti-neu antibody to local irradiation can improve tumor-bearing BALB/c mouse survival through immune-mediated mechanisms.
    Ma SY; Song H; Park JH; Choi JH; Kim JH; Kim KH; Park S; Park DH; Kang MS; Kwak M; Fu YX; Choi I; Cho H; Park S
    Radiat Res; 2015 Mar; 183(3):271-8. PubMed ID: 25706775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
    Hlavata Z; Solinas C; De Silva P; Porcu M; Saba L; Willard-Gallo K; Scartozzi M
    Target Oncol; 2018 Apr; 13(2):113-123. PubMed ID: 29470785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications.
    Bockel S; Durand B; Deutsch E
    Cancer Radiother; 2018 Oct; 22(6-7):567-580. PubMed ID: 30197026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of radiotherapy and immune checkpoint inhibitors.
    Pilones KA; Vanpouille-Box C; Demaria S
    Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.